GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy. [electronic resource]
Producer: 20100511Description: 605-10 p. digitalISSN:- 1473-5571
- Adolescent
- Adult
- Aged
- Anti-HIV Agents -- therapeutic use
- Antiretroviral Therapy, Highly Active
- CD4 Lymphocyte Count
- CD4-Positive T-Lymphocytes -- drug effects
- Female
- Flaviviridae Infections -- complications
- GB virus C -- isolation & purification
- HIV Infections -- complications
- HIV-1 -- isolation & purification
- Humans
- Interleukin-2 -- therapeutic use
- Male
- Middle Aged
- Recombinant Proteins -- therapeutic use
- Viremia -- complications
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.